Quantitative and ultrastructural analysis of inflammatory infiltrates in male pattern alopecia

Acta Dermato-Venereologica

Volumn 79, Issue 5, 1999, Pages 347-350

  Sueki, Hirohiko ^a,d   Stoudemayer, Tracy ^b   Kligman, Albert M ^a   Murphy, George F ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SKIN Inc   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adventitial sheaths; Bulge; Mast cells; Stem cell

Indexed keywords

ADULT; ADVENTITIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY INFILTRATE; MALE; MALE TYPE ALOPECIA; MAST CELL; PRIORITY JOURNAL; PUNCH BIOPSY; SCALP; ULTRASTRUCTURE;

ADOLESCENT; ADULT; ALOPECIA; CASE-CONTROL STUDIES; HAIR FOLLICLE; HUMANS; LYMPHOCYTES; MACROPHAGES; MALE; MAST CELLS; MICROSCOPY, ELECTRON; MIDDLE AGED;

EID: 0032870969     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155599750010238     Document Type: Article

References (18)

1. 1. Salamon T. Genetic factors in male pattern alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR, editors. Biopathology of pattern alopecia. Basel: Karger, 1968: 39-49.
2. 2. Lattanard A, Johnson WC. Male pattern alopecia: a histopathologic and histochemical study. J Cutan Pathol 1975; 2: 58-70.
3. 3. Jaworsky C, Kligman AM, Murphy GF. Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol 1992; 127: 239-246.
4. 4. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990; 61: 1329-1337.
5. 5. Picascia DD, Roenigk HH Jr. Effects of oral and topical cyclosporine in male pattern alopecia. Trans Proc 1988; 22, Suppl. 4: 109-111.
6. 6. Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathological study of 45 patients. J Am Acad Dermatol 1992; 27: 935-942.
7. 7. Wilson CL, Burge SM, Dean D, Dawber RPR. Scarring alopecia in discoid lupus erythematosus. Br J Dermatol 1992; 126: 307-314.
8. 8. Kossard S. Postmenopausal frontal fibrosing alopecia: scarring alopecia in a pattern distribution. Arch Dermatol 1994; 130: 770-774.
9. 9. Hatamochi A, Fujiwara K, Ueki H. Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch Dermatol Res 1985; 277: 60-64.
10. 10. Reed JA, Albino AP, McNutt NS. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995; 72: 215-222.
11. 11. Claman HN. Mast cell changes in a case of rapidly progressive scleroderma - ultrastructural analysis. J Invest Dermatol 1989; 92: 290-295.
12. 12. Torinuki W, Kudoh K., Tagami H. Increased mast cell numbers in the sclerotic skin of porphyria cutanea tarda. Dermatologica 1989; 178: 75-78.
13. 13. Kisher CW, Bunce H, Shetlar MR. Mast cell analysis in hypertrophic scars, hypertrophic scars treated with pressure and mature scars. J Invest Dermatol 1978; 70: 355-357.
14. 14. Jaffe BD, Claman HN. Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I Description of model systems. Cell Immunol 1983; 77: 1-12.
15. 15. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor-α which induces endothelial leukocyte adhesion molecule-1. Proc Natl Acad Sci USA 1991; 88: 4220-4224.
16. 16. Kanerva L, Jolanki R, Estlander T. Hair bulb accumulation of Langerhans cells in allergic patch tests. Acta Derm Venereol 1987; Suppl. 134: 64-68.
17. 17. Waldorf HA, Walsh LJ, Schechter NM, Murphy GF. Early cellular events in evolving cutaneous delayed hypersensitivity in humans. Am J Pathol 1991; 138: 477-486.
18. 18. Murphy GF, Lavker RM, Whitaker D, Korngold R. Cytotoxic folliculitis in acute graft-versus-host disease: Evidence of follicular stem cell injury and recovery. J Cutan Pathol 1990; 18: 309-314.